[NexVigilant Station] OpenVigil France

fda.govopen-vigil.fr/**v4by MatthewCampCorpAll tools verified

Open pharmacovigilance analytics โ€” disproportionality analysis on FAERS data with PRR, ROR, and IC computation DISCLAIMER: This WebMCP configuration was developed by NexVigilant, LLC and is provided as a community resource to assist AI agents in navigating pharmacovigilance and drug research tools. NexVigilant is not responsible for, and does not officially endorse third-party use of this configuration, and expressly disclaims any and all liability for damages of any kind arising out of the use, reference to, or reliance upon any information or actions performed through this resource. No guarantee is provided that the content is correct, accurate, complete, up-to-date, or that the underlying site structure has not changed. This tool is for educational and professional development purposes only and does not constitute medical or regulatory advice. Built by NexVigilant (https://nexvigilant.com) โ€” Empowerment Through Vigilance.

fdaorange-bookdrug-approvalstherapeutic-equivalencepatentexclusivitypharmacovigilancenexvigilantregulatory

Tools (2)2 verified

get-page-contentextractverified

0

by MatthewCampCorp

[NexVigilant Station] Extract the main content from any FDA drug approvals and databases page โ€” background text, resource lists, guidance links, and contact information.

Input Schema
{
  "type": "object",
  "properties": {}
}
Execution Metadata

Selector: article

Auto-submit: false

Result selector: article

Result extract: text

get-resource-linksextractverified

0

by MatthewCampCorp

[NexVigilant Station] Extract all resource links from FDA drug approvals pages โ€” Orange Book downloads, patent listings, exclusivity codes, guidance documents, and related database links.

Input Schema
{
  "type": "object",
  "properties": {}
}
Execution Metadata

Selector: article

Auto-submit: false

Result selector: article a[href]

Result extract: list

Config ID: a09c36fc-cef9-4296-b0cd-2a337f6ab133

Created: 3/6/2026

Updated: 3/8/2026